- Home
- BCRX vs CCS Comparison
BCRX vs CCS Comparison
Compare BCRX & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | CCS |
|---|---|---|
| Founded | 1986 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BCRX | CCS |
|---|---|---|
| Price | $7.20 | $61.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | $20.08 | ★ $70.50 |
| AVG Volume (30 Days) | ★ 4.0M | 231.3K |
| Earning Date | 11-03-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.93 |
| Revenue | $599,816,000.00 | ★ $4,157,669,000.00 |
| Revenue This Year | $40.20 | N/A |
| Revenue Next Year | $7.71 | $8.74 |
| P/E Ratio | ★ N/A | $8.87 |
| Revenue Growth | ★ 45.38 | N/A |
| 52 Week Low | $6.00 | $50.42 |
| 52 Week High | $11.31 | $83.23 |
Technical Indicators
Market Signals| Indicator | BCRX | CCS |
|---|---|---|
| Relative Strength Index (RSI) | 44.23 | 47.24 |
| Support Level | $7.23 | $60.05 |
| Resistance Level | $7.92 | $64.09 |
| Average True Range (ATR) | 0.35 | 1.81 |
| MACD | -0.02 | -0.16 |
| Stochastic Oscillator | 13.42 | 16.23 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About CCS Century Communities Inc.
Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.